A Nationwide Survey of Adoption and Perception of Pharmacogenomic Testing by U.S. Cardiologists

Authors: Eric Stanek, Christopher L. Sanders, Barnabie C. Agatep, Katherine A. Johansen, Ronald E. Aubert, Mona Khalid, Aanal Patel, Felix W. Frueh, Robert S. Epstein

Almost all sampled US cardiologists believe that a patient’s genetic makeup influences drug therapy response, however just 16% of cardiologists report having already adopted PGx testing into practice and 35% anticipate future adoption. Prior education exerted a strong influence on the adoption of PGx testing.

Citation: Journal of the American College of Cardiology, Volume 57, Issue 14, Supplement, 5 April 2011, Page E1283

Link: http://www.sciencedirect.com/science/article/pii/S0735109711612837?_alid=1839058922&_rdoc=1&_fmt=high&_origin=search&_docanchor=&_ct=1&_zone=rslt_list_item&md5=51a0da6382d12842fdd666de26f3d11c